Literature DB >> 17161926

Relationship between adolescent amenorrhea and climacteric osteoporosis.

Tamás Csermely1, László Halvax, Miklós Vizer, István Drozgyik, Péter Tamás, Péter Göcze, István Szabó, Sára Jeges, András Szilágyi.   

Abstract

OBJECTIVES: The relationship between climacteric osteoporosis and disturbances in menstrual cycle during adolescence was examined.
METHODS: Seven hundred and seventy-one questionnaires were shared out among women visiting the outpatient department for climacteric complaints for the first time between 2001 and 2004. Questions revealed the age, age at menarche and menopause, the regularity or irregularity of menstrual cycle during adolescence and adult ages. The bone mineral density was examined using the Dual Energy X-ray Absorptiometry (DEXA) method on the lumbar spine.
RESULTS: Six hundred and thirty-five of the 771 questionnaires were suitable for analysis. Osteoporosis was observed in 30.1% of the cases. Age, age at the menarche or at the menopause did not alter in the subgroups with or without osteoporosis. The incidence and severity of osteoporosis were significantly higher in patients reporting secondary amenorrhea during adolescent ages (42.1%; average BMD of the lumbar spine 71.6+/-3.9), as compared to the patients with normal cycle (30.4%; average BMD of the lumbar spine 84.8+/-7.8). No correlation between the occurrence of osteoporosis and the frequency of menstrual cycle during adulthood was observed.
CONCLUSIONS: Secondary amenorrhea during the years of adolescence might play a role in the development of more severe osteoporosis in menopause.

Entities:  

Mesh:

Year:  2006        PMID: 17161926     DOI: 10.1016/j.maturitas.2006.10.003

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  4 in total

Review 1.  Obstacles in the optimization of bone health outcomes in the female athlete triad.

Authors:  Gaele Ducher; Anne I Turner; Sonja Kukuljan; Kathleen J Pantano; Jennifer L Carlson; Nancy I Williams; Mary Jane De Souza
Journal:  Sports Med       Date:  2011-07-01       Impact factor: 11.136

2.  Menarche, menopause, years of menstruation, and the incidence of osteoporosis: the influence of prenatal exposure to diethylstilbestrol.

Authors:  Samantha E Parker; Rebecca Troisi; Lauren A Wise; Julie R Palmer; Linda Titus-Ernstoff; William C Strohsnitter; Elizabeth E Hatch
Journal:  J Clin Endocrinol Metab       Date:  2013-11-18       Impact factor: 5.958

3.  Rationale and study design of an intervention of increased energy intake in women with exercise-associated menstrual disturbances to improve menstrual function and bone health: The REFUEL study.

Authors:  Nancy I Williams; Rebecca J Mallinson; Mary Jane De Souza
Journal:  Contemp Clin Trials Commun       Date:  2019-01-18

4.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.